Clinical trial

Insulin Glargine Combination Therapies in Type II Diabetics

NCT00783744

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-12-01

PhasePHASE3

Study timeline

Study start (unknown)2001-12-01Date precision: month

Registry last updated2009-09-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Insulin GlargineDRUG · verified · RxNorm: insulin glargine

GlimepirideDRUG · verified · RxNorm: glimepiride

MetforminDRUG · verified · RxNorm: metformin

Insulin monotherapy with premixed insulin NPH 30/70DRUG

Sponsors & collaborators

Sanofilead sponsor

Mapped research locations

BarcelonaSpain1 ParisFrance1 BerlinGermany1 MilanItaly1 ViennaAustria1 HelsinkiFinland1 GenevaSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00783744 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.